Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation João Ferreira, Ana Mirco

Clinical and economic consequences of using dabigatran or rivaroxaban in patients with non-valvular atrial fibrillation Luís Silva Miguel, Jorge Ferreira

Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting João Morais, Carlos Aguiar, Euan McLeod, Ismini Chatzitheofilou, Isabel Fonseca Santos, Sónia Pereira